Literature DB >> 11511033

Linkage of chondroitin-sulfate to type I collagen scaffolds stimulates the bioactivity of seeded chondrocytes in vitro.

J Pieper, P Buma, T H van Kuppevelt, H van Beuningen, P M van Der Kraan, J H Veerkamp, W B van den Berg.   

Abstract

An increasing amount of interest is focused on the potential use of tissue-engineered articular cartilage implants, for repair of defects in the joint surface. In this perspective, various biodegradable scaffolds have been evaluated as a vehicle to deliver chondrocytes into a cartilage defect. This cell-matrix implant should eventually promote regeneration of the traumatized articular joint surface with hyaline cartilage. Successful regeneration can only be achieved with such a tissue-engineered cartilage implant if the seeded cells reveal an appropriate proliferation rate in the biodegradable scaffold together with the production of a new cartilage-specific extracellular matrix. These metabolic parameters can be influenced by the biochemical composition of a cell-delivery scaffold. Further elucidation of specific cell-matrix interactions is important to define the optimal biochemical composition of a cell-delivery vehicle for cartilage repair. In this in vitro study, we investigated the effect of the presence of cartilage-specific glycosaminoglycans in a type I collagen scaffold on the metabolic activity of seeded chondrocytes. Isolated bovine chondrocytes were cultured in porous type I collagen matrices in the presence and absence of covalently attached chondroitin sulfate (CS) up to 14 days. CS did indeed influence the bioactivity of the seeded chondrocytes. Cell proliferation and the total amount of proteoglycans retained in the matrix, were significantly higher (p < 0.001) in type I collagen scaffolds with CS. Light microscopy showed the formation of a more dense cartilaginous layer at the matrix periphery. Scanning electron microscopy revealed an almost complete surfacing of the initially porous surface of both matrices. Histology and reverse transcriptase PCR for various proteoglycan subtypes suggested a good preservation of the chondrocytic phenotype of the seeded cells during culture. The stimulatory potential of CS on both the cell-proliferation and matrix retention, turns this GAG into an interesting biochemical component of a cell-delivery scaffold for use in tissue-engineering articular cartilage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511033     DOI: 10.1016/s0142-9612(00)00423-3

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  39 in total

1.  Magnetic resonance studies of macromolecular content in engineered cartilage treated with pulsed low-intensity ultrasound.

Authors:  Onyi N Irrechukwu; Ping-Chang Lin; Kate Fritton; Steve Doty; Nancy Pleshko; Richard G Spencer
Journal:  Tissue Eng Part A       Date:  2010-10-25       Impact factor: 3.845

2.  The fundamental parameters of chitosan in polymer scaffolds affecting osteoblasts (MC3T3-E1).

Authors:  Wiroj Suphasiriroj; Pusadee Yotnuengnit; Rudee Surarit; Rath Pichyangkura
Journal:  J Mater Sci Mater Med       Date:  2008-09-13       Impact factor: 3.896

3.  Binding and release characteristics of insulin-like growth factor-1 from a collagen-glycosaminoglycan scaffold.

Authors:  Leanne M Mullen; Serena M Best; Roger A Brooks; Siddhartha Ghose; Jessica H Gwynne; John Wardale; Neil Rushton; Ruth E Cameron
Journal:  Tissue Eng Part C Methods       Date:  2010-05-22       Impact factor: 3.056

4.  Using chondroitin sulfate to improve the viability and biosynthesis of chondrocytes encapsulated in interpenetrating network (IPN) hydrogels of agarose and poly(ethylene glycol) diacrylate.

Authors:  Ganesh C Ingavle; Nathan H Dormer; Stevin H Gehrke; Michael S Detamore
Journal:  J Mater Sci Mater Med       Date:  2011-11-25       Impact factor: 3.896

5.  Biomedical Applications of Biodegradable Polymers.

Authors:  Bret D Ulery; Lakshmi S Nair; Cato T Laurencin
Journal:  J Polym Sci B Polym Phys       Date:  2011-06-15

6.  Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds.

Authors:  W D Yang; R R Gomes; M Alicknavitch; M C Farach-Carson; D D Carson
Journal:  Tissue Eng       Date:  2005 Jan-Feb

7.  Enhanced in vitro chondrogenesis of primary mesenchymal stem cells by combined gene transfer.

Authors:  Andre F Steinert; Glyn D Palmer; Carmencita Pilapil; Ulrich Nöth; Christopher H Evans; Steven C Ghivizzani
Journal:  Tissue Eng Part A       Date:  2009-05       Impact factor: 3.845

8.  Engineered articular cartilage: influence of the scaffold on cell phenotype and proliferation.

Authors:  Antonio Gigante; Claudia Bevilacqua; Massimo Cappella; Sandra Manzotti; Francesco Greco
Journal:  J Mater Sci Mater Med       Date:  2003-08       Impact factor: 3.896

9.  Characterization of collagen II fibrils containing biglycan and their effect as a coating on osteoblast adhesion and proliferation.

Authors:  Timothy Douglas; Sascha Heinemann; Ute Hempel; Carolin Mietrach; Christiane Knieb; Susanne Bierbaum; Dieter Scharnweber; Hartmut Worch
Journal:  J Mater Sci Mater Med       Date:  2007-09-13       Impact factor: 3.896

10.  Modification of silk fibroin using diazonium coupling chemistry and the effects on hMSC proliferation and differentiation.

Authors:  Amanda R Murphy; Peter St John; David L Kaplan
Journal:  Biomaterials       Date:  2008-04-15       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.